2seventy bio

United States
Primghar, Iowa, United States, 02142

Company profile

2seventy bio company profile

22seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies. The company combines a deep knowledge of cancer cell biology and genetics with an understanding of the immune response to cancer to advance its pipeline. It was established in Cambridge, Massachusetts in 2021.

Business identity

Contact email
[email protected]
Phone number
617-675-7270
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$1M-$10M
Founded
2021-01-01, Year

Headquarters

Postal code
02142
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$315M
Last funding
Post IPO Equity / $125M / 2023-02-28
Last equity funding
Post IPO Equity / $125M
Investors
15
Lead investors
1
Articles
151
Exited on
2021-10-18

Founders and investors

Lead investors

Regeneron

Investors

Bain Capital Life SciencesCasdin CapitalEcoR1 CapitalJanus Henderson InvestorsRTW Investments